Jan de Kerpel

Jan de Kerpel

Director of Research - Equity at Van Lanschot Kempen NV (Broker)

Consumer Services
Finance

Profile

Dr. Jan de Kerpel is a Managing Director, Head of Life Science & Healthcare at Van Lanschot Kempen NV.
He has more than 20 years of experience in the fields of drug development, equity analysis and capital market growth financing.
Prior to Kempen, Dr. de Kerpel was one decade Senior Equity Analyst, Pharma & Biotech at KBC Securities.
He started his professional activities in drug development at Tibotec-Virco (now JNJ) and Devgen (now Syngenta).
He earned a master and PhD in life sciences and postgraduate in Business Administration from Univ Leuve

Jan de Kerpel active positions

CompaniesPositionStart
Director of Research - Equity 31/08/2016
All active positions of Jan de Kerpel

Former positions of Jan de Kerpel

CompaniesPositionEnd
Analyst-Equity 31/07/2016
See the detail of Jan de Kerpel's experience

Training of Jan de Kerpel

Vlerick Leuven Gent Management School Masters Business Admin
Katholieke Universiteit Leuven Doctorate Degree
Hogeschool-Universiteit Brussel Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jan de Kerpel's experience

Connections

100 +

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies2

Finance

Finance

See company connections